Company Overview
PHATHOM PHARMACEUTICALS, INC.
PHATRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
175M
2025 FY
Net Income
-221M
2025 FY
Shares Outstanding
73M
2025 FY
EPS
-3.03USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1783183
Exchange
Nasdaq
Location
US